US Stock MarketDetailed Quotes

PALI Palisade Bio

Watchlist
  • 0.3991
  • +0.0038+0.96%
Close Mar 28 16:00 ET
5.10MMarket Cap-221P/E (TTM)

About Palisade Bio Company

Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. The company was founded on September 6, 2011 and is headquartered in Carlsbad, CA.

Company Profile

SymbolPALI
Company NamePalisade Bio
Listing Date08/27/2007
Founded2011
CEOMr. J. D. Finley
MarketNASDAQ
Employees9
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address7750 El Camino Real,Suite 5200
CityCarlsbad
ProvinceCalifornia
CountryUnited States of America
Zip Code93446
Phone1-858-704-4900

Company Executives

  • Name
  • Position
  • Salary
  • J. D. Finley
  • Director, Interim Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer
  • 1.11M
  • Dr. Mitchell Lawrence Jones
  • Chief Medical Officer
  • --
  • Donald A. Williams
  • Chairman of the Board
  • 131.59K
  • Binxian Wei
  • Independent Director
  • 119.35K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg